IV NEWS
News and innovation - February 5, 2024
Key insights on recent amendments to EU-MDR
The European Medical Device Regulation (EU-MDR) 2017/745 has brought many changes to the medical device industry and product availability. Thanks…
Events and training February 1, 2024
PICC line or port catheter: Which one for cancer patients?
It can be challenging knowing when to insert a peripherally inserted central catheter (PICC line) or port catheter into patients…
“Complications of IV catheter therapy are simply the result of one complex and highly variable mechanical system—IV catheter equipment design,...
News and innovation January 22, 2024
Quality control of prefilled flush syringes: key considerations
Before delving into the quality control of prefilled flush syringes, which are an integral part of vascular access management (VAM),…
News and innovation January 15, 2024
Antibiotics shortages in Europe: what you need to know
“A new approach is needed to better tackle medicines shortages in the European Health Union,” the European Commission said in…
Events and training January 8, 2024
Safe connections webinar: open vs closed IV access
How can we define safe connections? Connections are critical junctures and/or points of access along intravenous (IV) lines. Microorganisms may…
Events and training January 2, 2024
Spanish vascular access team refines device selection algorithm
The Vall D’Hebron Hospital in Barcelona, Spain treats over 1.2 million patients per year, with 1,100 beds and a team…
News and innovation December 21, 2023
PICCs in intensive care units: new Spanish guidelines fill a gap
When and how should peripherally inserted central catheters (PICCs) be used in intensive care units (ICUs)? At the end of 2022,…
Fast fact
TIVA anaesthesia
Propofol-based total intravenous anaesthesia (TIVA) emits four orders of magnitude less greenhouse gases than inhaled anaesthesia with desflurane and N2O.